Goldman Sachs’s Galmed Pharmaceuticals GLMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-26,419
| Closed | -$91K | – | 5437 |
|
|
2021
Q1 | $91K | Buy |
+26,419
| New | +$91K | ﹤0.01% | 5054 |
|
|
2020
Q2 | – | Sell |
-17,814
| Closed | -$62K | – | 4438 |
|
|
2020
Q1 | $62K | Buy |
+17,814
| New | +$62K | ﹤0.01% | 4242 |
|
|
2019
Q2 | – | Sell |
-16,900
| Closed | -$138K | – | 4222 |
|
|
2019
Q1 | $138K | Buy |
+16,900
| New | +$138K | ﹤0.01% | 3965 |
|
|
2016
Q2 | – | Sell |
-11,831
| Closed | -$58K | – | 4564 |
|
|
2016
Q1 | $58K | Sell |
11,831
-3,221
| -21% | -$15.8K | ﹤0.01% | 4178 |
|
|
2015
Q4 | $115K | Sell |
15,052
-19,061
| -56% | -$146K | ﹤0.01% | 3937 |
|
|
2015
Q3 | $253K | Sell |
34,113
-7,878
| -19% | -$58.4K | ﹤0.01% | 3704 |
|
|
2015
Q2 | $422K | Sell |
41,991
-5,260
| -11% | -$52.9K | ﹤0.01% | 3465 |
|
|
2015
Q1 | $445K | Buy |
47,251
+132
| +0.3% | +$1.24K | ﹤0.01% | 3393 |
|
|
2014
Q4 | $273K | Buy |
47,119
+33,500
| +246% | +$194K | ﹤0.01% | 3764 |
|
|
2014
Q3 | $117K | Buy |
+13,619
| New | +$117K | ﹤0.01% | 4185 |
|